Immunome Stock Technical Analysis

IMNM Stock  USD 8.55  0.11  1.27%   
As of the 21st of March, Immunome retains the Risk Adjusted Performance of (0.13), market risk adjusted performance of (0.34), and Standard Deviation of 4.26. Immunome technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Immunome variance and potential upside to decide if Immunome is priced fairly, providing market reflects its last-minute price of 8.55 per share. Given that Immunome has information ratio of (0.14), we strongly advise you to confirm Immunome's regular market performance to make sure the company can sustain itself at a future point.

Immunome Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Immunome, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Immunome
  
Immunome's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Immunome Analyst Consensus

Target PriceAdvice# of Analysts
30.0Strong Buy7Odds
Immunome current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Immunome analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Immunome stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Immunome, talking to its executives and customers, or listening to Immunome conference calls.
Immunome Analyst Advice Details
Immunome technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Immunome technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Immunome trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Immunome Technical Analysis

Indicator
Time Period
Execute Indicator
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Immunome volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Immunome Trend Analysis

Use this graph to draw trend lines for Immunome. You can use it to identify possible trend reversals for Immunome as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Immunome price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Immunome Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Immunome applied against its price change over selected period. The best fit line has a slop of   0.04  , which may suggest that Immunome market price will keep on failing further. It has 122 observation points and a regression sum of squares at 49.02, which is the sum of squared deviations for the predicted Immunome price change compared to its average price change.

About Immunome Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Immunome on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Immunome based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Immunome price pattern first instead of the macroeconomic environment surrounding Immunome. By analyzing Immunome's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Immunome's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Immunome specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2022 2023 2024 2025 (projected)
Current Ratio3.096.634.084.22
Net Debt To EBITDA0.553.430.921.09

Immunome March 21, 2025 Technical Indicators

Most technical analysis of Immunome help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Immunome from various momentum indicators to cycle indicators. When you analyze Immunome charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Immunome March 21, 2025 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Immunome stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
When determining whether Immunome is a strong investment it is important to analyze Immunome's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Immunome's future performance. For an informed investment choice regarding Immunome Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunome. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
To learn how to invest in Immunome Stock, please use our How to Invest in Immunome guide.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunome. If investors know Immunome will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunome listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(7.94)
Revenue Per Share
0.189
Quarterly Revenue Growth
(0.18)
Return On Assets
(0.40)
Return On Equity
(2.76)
The market value of Immunome is measured differently than its book value, which is the value of Immunome that is recorded on the company's balance sheet. Investors also form their own opinion of Immunome's value that differs from its market value or its book value, called intrinsic value, which is Immunome's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunome's market value can be influenced by many factors that don't directly affect Immunome's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunome's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunome is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunome's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.